Racial Differences in Genomic Profiling of Prostate Cancer

Clinical use of current polygenic risk scores may exacerbate health disparities

Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0379-x · Cited by 2,821

AACR Project GENIE: Powering Precision Medicine through an International Consortium

The AACR Project GENIE Consortium, The AACR Project GENIE Consortium, André, F., Arnedos, M., Baras, A. S., Baselga, J., Bedard, P. L., Berger, M. F., Bierkens, M., Calvo, F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0151 · Cited by 1,964

Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality

Dess, R. T., Hartman, H. E., Mahal, B. A. V., Soni, P., Jackson, W., Cooperberg, M. R., Amling, C. L., Aronson, W. J., Kane, C. J., Terris, M. K., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0826 · Cited by 416

Disparities in Castration-Resistant Prostate Cancer Trials

Spratt, D. E., & Osborne, J. R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.1751 · Cited by 57

Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores

Mahal, B. A. V., Alshalalfa, M., Spratt, D. E., Davicioni, E., Zhao, S. G., Feng, F. Y.-C., Rebbeck, T. R., Nguyen, P. L., & Huang, F. W. (2019) · European Urology · doi:10.1016/j.eururo.2019.01.010 · Cited by 53

2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review

Bergengren, O., Pekala, K. R., Matsoukas, K., Fainberg, J. S., Mungovan, S. F., Ola Bratt, A., Bray, F., Brawley, O. W., Luckenbaugh, A. N., Mucci, L. A., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.04.021 · Cited by 934

The Lancet Commission on prostate cancer: planning for the surge in cases

James, N. D., Tannock, I. F., N'Dow, J. M., Feng, F. Y.-C., Gillessen, S., Ali, A., Trujillo, B., Al‐Lazikani, B., Attard, G., Bray, F., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00651-2 · Cited by 826

Algorithmic fairness in artificial intelligence for medicine and healthcare

Chen, R. J., Wang, J. J., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Lu, M. Y., Sahai, S., & Mahmood, F. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01056-8 · Cited by 750

Cancer statistics for African American/Black People 2022

Giaquinto, A. N., Miller, K. D., Tossas, K. Y., Winn, R. A., Jemal, A., & Siegel, R. L. (2022) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21718 · Cited by 591

Cancer in sub-Saharan Africa: a Lancet Oncology Commission

Ngwa, W. F., Addai, B. W., Adewole, I. F., Ainsworth, V., Alaro, J., Alatise, O. I., Ali, Z. V., Anderson, B. O., Anorlu, R. I., Avery, S., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00720-8 · Cited by 460

Epidemiology and genomics of prostate cancer in Asian men

Zhu, Y., Mo, M., Yu, W., Wu, J., Pan, J. G., Freedland, S. J., Zheng, Y., & Ye, D. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00442-8 · Cited by 293

Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions

Lotter, W., Hassett, M. J., Schultz, N., Kehl, K. L., Van Allen, E. M., & Cerami, E. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1199 · Cited by 196

Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview

Hinata, N., & Fujisawa, M. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.210070 · Cited by 119

Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics

Lowder, D., Rizwan, K., McColl, C., Paparella, A. T., Ittmann, M., Mitsiades, N., & Kaochar, S. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.028 · Cited by 118

AACR Project GENIE: 100,000 Cases and Beyond

Pugh, T. J., Bell, J. L., Bruce, J. P., Doherty, G. J., Galvin, M., Green, M. F., Hunter-Zinck, H., Kumari, P., Lenoue-Newton, M. L., Li, M. M., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1547 · Cited by 107

Racial disparities in prostate cancer among black men: epidemiology and outcomes

Chowdhury-Paulino, I. M., Ericsson, C. I., Vince, R., Spratt, D. E., George, D. J., & Mucci, L. A. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00451-z · Cited by 101

Biomarkers of Aggressive Prostate Cancer at Diagnosis

Boehm, B. E., York, M. E., Petrovics, G., Kohaar, I., & Chesnut, G. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032185 · Cited by 86

Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia

Bhatnagar, B., Kohlschmidt, J., Mrózek, K., Zhao, Q., Fisher, J. L., Nicolet, D., Walker, C. J., Mims, A. S., Oakes, C. C., Giacopelli, B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1579 · Cited by 85

Cancer statistics for African American and Black people, 2025

Saka, A. H., Giaquinto, A. N., McCullough, L. E., Tossas, K. Y., Star, J., Jemal, A., & Siegel, R. L. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21874 · Cited by 95

African-specific molecular taxonomy of prostate cancer

Jaratlerdsiri, W., Jiang, J., Gong, T., Patrick, S. M., Willet, C. E., Chew, T., Lyons, R. J., Haynes, A., Pasqualim, G., Louw, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05154-6 · Cited by 75

A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research

Rebbeck, T. R., Bridges, J. F. P., Mack, J. W., Gray, S. W., Trent, J. M., George, S., Crossnohere, N. L., Paskett, E. D., Painter, C., Wagle, N., et al. (2022) · JAMA Health Forum · doi:10.1001/jamahealthforum.2022.0603 · Cited by 68

Germline and somatic genomic testing for metastatic prostate cancer: ASCO guideline

Yu, E. Y., Rumble, R. B., Agarwal, N., Cheng, H. H., Eggener, S. E., Bitting, R. L., Beltran, H., Giri, V. N., Spratt, D., Mahal, B., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-02608 · Cited by 64

Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors

Stopsack, K. H., Nandakumar, S., Arora, K. S., Nguyen, B., Vasselman, S. E., Nweji, B., McBride, S. M., Morris, M. J., Rathkopf, D. E., Slovin, S. F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2577 · Cited by 60

Clinical and genomic features of SPOP‐mutant prostate cancer

Nakazawa, M., Fang, M., Marshall, C. H., Lotan, T. L., Velho, P. I., & Antonarakis, E. S. (2021) · The Prostate · doi:10.1002/pros.24269 · Cited by 55

Genomic Profiling of Prostate Cancer: An Updated Review

Hatano, K., & Nonomura, N. (2021) · The World Journal of Men s Health · doi:10.5534/wjmh.210072 · Cited by 56

Disparities in germline testing among racial minorities with prostate cancer

Weise, N., Shaya, J. A., Javier-DesLoges, J. F., Cheng, H. H., Madlensky, L., & McKay, R. R. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00469-3 · Cited by 46

Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer

Ledet, E. M., Burgess, E. F., Sokolova, A. O., Jaeger, E., Hatton, W., Moses, M. W., Miller, P., Cotogno, P., Layton, J. L., Barata, P. C., et al. (2021) · The Prostate · doi:10.1002/pros.24123 · Cited by 43

The distinct impacts of race and genetic ancestry on health

Rebbeck, T. R., Mahal, B. A. V., Maxwell, K. N., Garraway, I. P., & Yamoah, K. (2022) · Nature Medicine · doi:10.1038/s41591-022-01796-1 · Cited by 45

Racial and ethnic disparities in a real-world precision oncology data registry

Cheung, A. T. M., Palapattu, E. L., Pompa, I. R., Aldrighetti, C. M., Niemierko, A., Willers, H., Huang, F., Vapiwala, N., Van Allen, E., & Kamran, S. C. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00351-6 · Cited by 39

Health inequity drives disease biology to create disparities in prostate cancer outcomes

Nelson, W. G., Brawley, O. W., Isaacs, W. B., Platz, E. A., Yegnasubramanian, S., Sfanos, K. S., Lotan, T. L., & Marzo, A. M. D. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155031 · Cited by 42

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

Jiagge, E. M., Jin, D. X., Newberg, J. Y., Perea-Chamblee, T. E., Pekala, K. R., Fong, C. J., Waters, M., Ma, D., Dei‐Adomakoh, Y., Erb, G., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.10.003 · Cited by 39

The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response

Berchuck, J. E., Adib, E., Alaiwi, S. A., Dash, A. K., Shin, J. N., Lowder, D., McColl, C., Castro, P. D., Carelli, R., Benedetti, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3552 · Cited by 38

ETS factors in prostate cancer

Qian, C., Li, D., & Chen, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.009 · Cited by 39

Race and prostate cancer: genomic landscape

Gallo, C. A., Owiredu, J. N., Weinstein, I., Lewicki, P., Basourakos, S. P., Vince, R., Awamlh, B. A. H. A., Schumacher, F. R., Spratt, D. E., Barbieri, C. E., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00622-0 · Cited by 36

A novel prostate cancer subtyping classifier based on luminal and basal phenotypes

Weiner, A. B., Liu, Y., Hakansson, A., Zhao, X., Proudfoot, J. A., Ho, J., Zhang, J. H., Li, E. V., Karnes, R. J., Den, R. B., et al. (2023) · Cancer · doi:10.1002/cncr.34790 · Cited by 37

Genetic and biological drivers of prostate cancer disparities in Black men

Gong, J., Kim, D. M., Freeman, M. R., Kim, H. L., Ellis, L., Smith, B., Theodorescu, D., Posadas, E. M., Figlin, R. A., Bhowmick, N. A., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00828-w · Cited by 38

PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer

Koshkin, V. S., Patel, V. G., Ali, A., Bilen, M. A., Ravindranathan, D., Park, J. J., Kellezi, O., Cieslik, M. P., Shaya, J. A., Cabal, A., et al. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00433-1 · Cited by 30

Tumor Mutations Across Racial Groups in a Real-World Data Registry

Kamran, S. C., Xie, J., Cheung, A. T. M., Mavura, M. Y., Song, H., Palapattu, E. L., Madej, J., Gusev, A., Allen, E. M. V., & Huang, F. W. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00340 · Cited by 28

Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards

Dee, E. C., Todd, R., Ng, K., Aidoo-Micah, G., Amen, T. B., Moon, Z., Vince, R., Muralidhar, V., Mutsvangwa, K., Funston, G., et al. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00948-x · Cited by 28

Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men

Swami, N. S., Baez, Y. A., Franco, I. “., Nguyen, T., Meiyappan, K. P., Ton, M., Jain, B., Seldon, C. S., Ng, K., Duma, N., et al. (2022) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-022-00526-5 · Cited by 28

Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases

Shui, I. M., Burcu, M., Shao, C., Chen, C., Liao, C.-Y., Jiang, S., Cristescu, R., & Parikh, R. B. (2023) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-023-00764-1 · Cited by 24

Race and Genetic Alterations in Prostate Cancer

Schumacher, F. R., Basourakos, S. P., Lewicki, P., Vince, R., Spratt, D. E., Barbieri, C. E., & Shoag, J. E. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00324 · Cited by 22

The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients

Hoadley, A., Bass, S. B., Chertock, Y., Brajuha, J. A., D’Avanzo, P. A., Kelly, P. J. A., & Hall, M. J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052598 · Cited by 22

Relative impact of genetic ancestry and neighborhood socioeconomic status on all-cause mortality in self-identified African Americans

Iyer, H. S., Gomez, S. L., Cheng, I. C., & Rebbeck, T. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273735 · Cited by 22

Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients

Fang, B., Yu, W., Zeng, H., Li, Y., Chen, S., Zhang, T., Pan, J. G., Wang, B., Wu, J., Jin, S., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03347-6 · Cited by 22

ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer

Li, D., Zhan, Y., Wang, N., Tang, F., Lee, C. J., Bayshtok, G., Moore, A. R., Wong, E. W. P., Pachai, M. R., Xie, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adc9446 · Cited by 21

Mechanistic insights into genetic susceptibility to prostate cancer

Tian, P. W., Zhong, M., & Wei, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.025 · Cited by 22

Evolution of Disparities in Prostate Cancer Treatment: Is This a New Normal?

Cackowski, F. C., Mahal, B. A. V., Heath, E. I., & Carthon, B. C. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_321195 · Cited by 19

Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities

Marima, R. M., Hull, R., Mbeje, M., Molefi, T., Mathabe, K., Elbagory, A. M., Demetriou, D., & Dlamini, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020628 · Cited by 20

Clinical implications of homologous recombination repair mutations in prostate cancer

Morgado, P. C., & Mateo, J. (2022) · The Prostate · doi:10.1002/pros.24352 · Cited by 19

Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies

Zurita, A. J., Graf, R. P., Villacampa, G. J., Raskina, K., Sokol, E. S., Jin, D. X., Antonarakis, E. S., Li, G., Huang, R. S. P., Casanova‐Salas, I., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.22.00195 · Cited by 18

Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis

Sivakumar, S., Lee, J., Moore, J. A., Hopkins, J. F., Newberg, J. Y., Madison, R. W., Graf, R. P., Schrock, A. B., Kobetz, E. N., Vince, R., et al. (2023) · The Lancet Digital Health · doi:10.1016/s2589-7500(23)00053-5 · Cited by 18

The future of patient-derived xenografts in prostate cancer research

Lawrence, M. G., Taylor, R. A., Cuffe, G. B., Ang, L. S., Clark, A. K., Goode, D. L., Porter, L. H., Magnen, C. L., Navone, N. M., Schalken, J. A., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-022-00706-x · Cited by 19

Unique Spectrum of Activating BRAF Alterations in Prostate Cancer

Chehrazi‐Raffle, A., Tukachinsky, H., Toye, E., Sivakumar, S., Schrock, A. B., Bergom, H. E., Ebrahimi, H., Pal, S. K., Dorff, T. B., Agarwal, N., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1393 · Cited by 17

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer

Hwang, C., Henderson, N., Chu, S., Holland, B., Cackowski, F. C., Pilling, A. B., Jang, A., Rothstein, S. E., Labriola, M., Park, J. J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.34208 · Cited by 17

Prostate cancer and the social construct of race

Brawley, O. W. (2021) · Cancer · doi:10.1002/cncr.33417 · Cited by 15

Understanding Racial Disparities in Prostate Cancer: A Multifaceted Approach

Cobbs, C., Chesnut, G. T., & Shafi, A. A. (2025) · Cancer Medicine · doi:10.1002/cam4.70979 · Cited by 15

Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study

Prizment, A. E., McSweeney, S. T., Pankratz, N., Joshu, C. E., Hwang, J. H., Platz, E. A., & Ryan, C. J. (2021) · Cancers · doi:10.3390/cancers13081958 · Cited by 15

Molecular features and race‐associated outcomes of SPOP ‐mutant metastatic castration‐resistant prostate cancer

Stangl, A., Wilner, C., Li, P., Maahs, L., Hwang, C., & Pilling, A. B. (2023) · The Prostate · doi:10.1002/pros.24481 · Cited by 15

Role of the Immune Microenvironment in SARS-CoV-2 Infection

Ye, C.-H., Hsu, W., Peng, G.-R., Yu, W.-C., Lin, W., Hu, S., & Yu, S. (2021) · Cell Transplantation · doi:10.1177/09636897211010632 · Cited by 15

Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients

Liu, Y., Zhou, J., Liu, C., Yang, J.-K., Liao, D.-Y., Liang, Z.-J., Xie, X., Zhou, Q.-Z., Xue, K., Guo, W., et al. (2021) · Aging · doi:10.18632/aging.203158 · Cited by 14

Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms

Belleau, P., Deschênes, A., Chambwe, N., Tuveson, D. A., & Krasnitz, A. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0682 · Cited by 14

Somatic Tumor Next-Generation Sequencing in US Veterans With Metastatic Prostate Cancer

Valle, L., Li, J., Desai, H., Hausler, R. M., Haroldsen, C. L., Chatwal, M. S., Ojo, M., Kelley, M. J., Rebbeck, T. R., Rose, B. S., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.9119 · Cited by 13

Social Risk Factors in Society of Thoracic Surgeons Risk Models. Part 2: Empirical Studies in Cardiac Surgery; Risk Model Recommendations

Shahian, D. M., Badhwar, V., O’Brien, S. M., Habib, R., Han, J. M., McDonald, D., Antman, M. S., Higgins, R. S. D., Preventza, O. A., Estrera, A. L., et al. (2022) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2021.11.069 · Cited by 14

Ethnic Pharmacogenomic Differences in the Management of Asian Patients with Metastatic Prostate Cancer

Poon, D. M. C., Chan, K., Chan, T., Cheung, F.-Y., Lam, D. C. M., Martin Ho Ching, L. A. M., Law, K., Lee, C., Lee, E. K., Leung, A. K., et al. (2022) · Cancers · doi:10.3390/cancers14020407 · Cited by 14

An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry

Tourneau, C. L., Perret, C., Hackshaw, A. K., Blay, J., Nabholz, C. E., Geißler, J., Do, T., von Meyenn, M., & Dienstmann, R. (2022) · JCO Precision Oncology · doi:10.1200/po.22.00019 · Cited by 13

Prostate tumors of native men from West Africa show biologically distinct pathways—A comparative genomic study

Yamoah, K., Asamoah, F. A., Abrahams, A. O. D., Awasthi, S., Mensah, J. E., Dhillon, J., Mahal, B. A. V., Gueye, S. M., Jalloh, M., Farahani, S. J., et al. (2021) · The Prostate · doi:10.1002/pros.24238 · Cited by 12

Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans

Valle, L., Nickols, N. G., Hausler, R. M., Alba, P. R., Anglin-Foote, T. R., Perez, C., Yamoah, K., Rose, B. S., Kelley, M. J., DuVall, S. L., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad042 · Cited by 12

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race

Kensler, K. H., Awasthi, S., Alshalalfa, M., Trock, B. J., Freedland, S. J., Freeman, M. R., You, S., Mahal, B. A. V., Den, R. B., Dicker, A. P., et al. (2022) · European Urology Open Science · doi:10.1016/j.euros.2022.03.014 · Cited by 11

Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South Africa

Temilola, D. O., Wium, M., Paccez, J. D., Salukazana, A. S., Rotimi, S. O., Otu, H. H., Carbone, G. M., Kaestner, L., Cacciatore, S., & Zerbini, L. F. (2023) · Genes · doi:10.3390/genes14101884 · Cited by 11

Geography Should Not Be an “Oncologic Destiny” for Urothelial Cancer: Improving Access to Care by Removing Local, Regional, and International Barriers

Joshi, M., Polimera, H. V., Krupski, T. L., & Necchi, A. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_350478 · Cited by 11

Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access

Fenton, S. E., VanderWeeler, D. J., Rebbeck, T. R., & Chen, D. L. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_433138 · Cited by 12

Racial disparity in prostate cancer: an outlook in genetic and molecular landscape

Kaushal, J., Raut, P., Muniyan, S., Siddiqui, J. A., Alsafwani, Z. W., Seshacharyulu, P., Nair, S. S., Tewari, A. K., & Batra, S. K. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10193-8 · Cited by 10

Clinical Informatics Approaches to Understand and Address Cancer Disparities

Chaunzwa, T. L., del Rey, M. Q., & Bitterman, D. S. (2022) · Yearbook of Medical Informatics · doi:10.1055/s-0042-1742511 · Cited by 10

FOXD1‐AS1 promotes malignant behaviours of prostate cancer cells via the miR‐3167/YWHAZ axis

Qu, W., Wei, X., Zhang, H., & Hou, J. (2021) · Andrologia · doi:10.1111/and.14263 · Cited by 10

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity

Yu, W., Zhang, T., Wang, B., Pan, J. G., Jin, S., Fang, B., Gu, W., Qin, X., Dai, B., Lin, G., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13511 · Cited by 9

Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis

Alshalalfa, M., Nguyen, T., Stopsack, K. H., Khan, A., Franco, I. “., Seldon, C. S., Swami, N. S., Jin, W. H., Meiyappan, K. P., Ton, M., et al. (2022) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2022.10.002 · Cited by 9

Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?

Cussenot, O., Cancel‐Tassin, G., Rao, S. R., Woodcock, D. J., Lamb, A. D. G., Mills, I. G., & Hamdy, F. C. (2023) · British Journal of Urology · doi:10.1111/bju.16120 · Cited by 10

Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis

Vigneswaran, H. T., Mittelstaedt, L., Crippa, A., Eklund, M., Vidal, A. C., Freedland, S. J., & Abern, M. R. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00425-1 · Cited by 9

Risk factors influencing chronic inflammation in neoplastic transition to prostate cancer

Prakash, P., Verma, S., & Gupta, S. (2024) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2024.52 · Cited by 8

A Need for More Molecular Profiling in Brain Metastases

Shen, E., Swearingen, A. E. D. V., Price, M. J., Bulsara, K. R., Verhaak, R. G. W., Baëta, C. D., Painter, B., Reitman, Z. J., Salama, A. K. S., Clarke, J. M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.785064 · Cited by 8

The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa

Mabuka, T., Ncube, N., Ross, M., Silaji, A., Macharia, W., Ndemera, T., & Lemeke, T. (2023) · BMC Public Health · doi:10.1186/s12889-023-16162-0 · Cited by 8

Immune mechanisms behind prostate cancer in men of African ancestry: A review

Sentana‐Lledo, D., Sartor, O. A., Balk, S. P., & Einstein, D. J. (2022) · The Prostate · doi:10.1002/pros.24333 · Cited by 9

Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology

Chiu, P. K., Lee, E. K., Chan, M. T. Y., Chan, W. H. C., Cheung, M., Martin Ho Ching, L. A. M., Ma, E. S. K., & Poon, D. M. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.962958 · Cited by 9

Racial variation in the advanced prostate cancer genome

Feng, E., Vo-Phamhi, J. M., Subramanian, A., Dias, M., Foye, A., Vinson, J., Hong, J. C., Freedland, S. J., Alumkal, J. J., Beltran, H., et al. (2025) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-025-00949-w · Cited by 7

Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer

Lee, K. Y., Beatson, E. L., Steinberg, S. M., Chau, C. H., Price, D. K., & Figg, W. D. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01534-4 · Cited by 7

Androgen Deprivation Therapy and Outcomes After Radiation Therapy in Black Patients With Prostate Cancer

Morgan, K. M., Riviere, P. J., Nelson, T. J., Guram, K., Deshler, L. N., Minarim, D. S., Duran, E. A., Banegas, M. P., & Rose, B. S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.15911 · Cited by 7

Deciphering gene expression patterns using large-scale transcriptomic data and its applications

Chen, S., Wang, P., Guo, H., & Zhang, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae590 · Cited by 7

Regulatory genes in the androgen production, uptake and conversion (APUC) pathway in advanced prostate cancer

McSweeney, S. T., Bergom, H. E., Prizment, A. E., Halabi, S., Sharifi, N., Ryan, C. J., & Hwang, J. H. (2022) · Endocrine Oncology · doi:10.1530/eo-22-0058 · Cited by 7

Differences in metabolomic profiles between Black and White women in the U.S.: Analyses from two prospective cohorts

McGee, E. E., Zeleznik, O. A., Balasubramanian, R., Hu, J., ROSNER, B. A., Wactawski‐Wende, J., Clish, C. B., Ávila-Pacheco, J., Willett, W. C., Rexrode, K. M., et al. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01111-x · Cited by 6

Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression

Dióssy, M., Tisza, V., Li, H., Sahgal, P., Zhou, J., Sztupinszki, Z. M., Young, D., Nousome, D., Kuo, H., Jiang, J., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00705-8 · Cited by 6

Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection

Vangeti, S., Periasamy, S., Sun, P., Balinsky, C. A., Mahajan, A. S., Kuzmina, N. A., Schanoski, A. S., Cooper, E. S., Beckett, C. G., Marayag, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01837-22 · Cited by 7

Prostate cancer genetic alterations in Hispanic men

Gallo, C. A., Rhodes, S., Garcia, J. A., Weinstein, I., Prunty, M. C., Lewicki, P., Brant, A., Basourakos, S. P., Barbieri, C. E., Lifschutz, N., et al. (2023) · The Prostate · doi:10.1002/pros.24586 · Cited by 6

Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients

Cussenot, O., Timms, K. M., Perrot, E., Blanchet, P., Brureau, L., Solimeno, C., Fromont, G., Compérat, É., & Cancel‐Tassin, G. (2024) · European Urology Oncology · doi:10.1016/j.euo.2023.12.003 · Cited by 6

Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men

Gong, T., Jiang, J., Uthayopas, K., Bornman, R. M. S., Gheybi, K., Stricker, P. D., Weischenfeldt, J., Mutambirwa, S. B. A., Jaratlerdsiri, W., & Hayes, V. M. (2025) · Nature Communications · doi:10.1038/s41467-025-57312-9 · Cited by 7

Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer

Vidotto, T., Imada, E. L., Faisal, F. A., Murali, S., Mendes, A. A. D. A., Kaur, H. B., Zheng, S. L., Xu, J., Schaeffer, E. M., Isaacs, W. B., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.162409 · Cited by 6

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care

Sindhu, K. K., Dovey, Z. S., Thompson, M., Nehlsen, A. D., Skalina, K. A., Małachowska, B., Hasan, S., Guha, C., Tang, J., & Salgado, L. R. (2024) · BJUI Compass · doi:10.1002/bco2.323 · Cited by 5

Racial Disparities in Prostate Cancer Stage at Diagnosis Persist Despite Community Affluence

Nemesure, B. B., Scarbrough, K. H., & Mermelstein, L. (2022) · Research and Reports in Urology · doi:10.2147/rru.s371838 · Cited by 5

Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate Cancer

Thapa, B., Venturini, J., Choudhury, A. D., & Francini, E. (2026) · Cancers · doi:10.3390/cancers18111702 · Cited by 4

Tumor Molecular Profiling in Hispanics: Moving Towards Precision Oncology and Health Equity

Rodríguez, S. M., Rodríguez-Hernández, A. M., Torres-Torres, G., Centeno‐Girona, H., & Cruz-Correa, M. R. (2022) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-022-01328-0 · Cited by 4

Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective

Matsumoto, T., Shiota, M., Blas, L., & Eto, M. (2022) · Cancer Management and Research · doi:10.2147/cmar.s326114 · Cited by 4

Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and Sex

Wen, W., Choi, J. Y., Singh, B., Li, L., Toriola, A. T., Ciombor, K. K., Park, B. H., Shu, X., Idrees, K., Zheng, W., et al. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-25-0345 · Cited by 4

Outcomes for Patients With SPOP Mutated Castration-Resistant Prostate Cancer (CRPC) Treated With an Androgen Receptor Pathway Inhibitor (ARPI)

Park, J. J., Howard, L. E., Fragkogianni, S., George, D. J., & Armstrong, A. J. (2026) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2026.102502 · Cited by 3

PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer

Cunningham, M. L., & Schiewer, M. J. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3458 · Cited by 3

Investigating Intensity and Percentage of p53 Nuclear Expression in Prostate Cancer: Findings from a Cohort of U.S. Military Veterans

Gesztes, W., Lap, C. J. G., Rajendran, R., Dalivand, M. M., Diao, G., Liu, S., Jain, M. M., & Nava, V. E. (2025) · Cancers · doi:10.3390/cancers17061004 · Cited by 3

Molecular Discriminators of Racial Disparities in Prostate Cancer

Ateeq, B., Bhatia, V., & Goel, S. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.01.005 · Cited by 11

Genetic ancestry associations with somatic mutations in a real-world cohort of over 3,000 patients with prostate cancer.

Vega, F. M. D. L., Rhead, B. L., Pouliot, Y., Guinney, J., Craig, D. W., & Carpten, J. D. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.2023.41.16_suppl.5034

Race and prostate cancer: genomic landscape

Gallo, C. A., Owiredu, J. N., Weinstein, I., Lewicki, P., Basourakos, S. P., Vince, R., Awamlh, B. A. H. A., Schumacher, F. R., Spratt, D. E., Barbieri, C. E., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00622-0 · Cited by 36

Abstract C045: Investigating molecular and genetic contributions to racial disparities in prostate cancer by integrating multi-omic datasets available in public

Hightower, A. J., Rhie, S. K., Falzarano, S. M., & Buxbaum, S. G. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1538-7755.disp22-c045

Gene Alterations Linked to Prostate Cancer Disparities

Froelich, W. (2020) · Oncology Times · doi:10.1097/01.cot.0000725488.32051.39